Why is Auro Laboratories Ltd ?
1
High Management Efficiency with a high ROCE of 18.05%
2
Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.58 times
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.58 times
3
Poor long term growth as Net Sales has grown by an annual rate of -13.87% and Operating profit at -20.09% over the last 5 years
4
With a growth in Net Profit of 170.83%, the company declared Very Positive results in Dec 25
- NET SALES(Latest six months) Higher at Rs 18.23 cr
- PBDIT(Q) Highest at Rs 4.06 cr.
- PBT LESS OI(Q) Highest at Rs 1.56 cr.
5
With ROCE of 2.5, it has a Very Expensive valuation with a 2.4 Enterprise value to Capital Employed
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 16.83%, its profits have fallen by -15.2%
6
Majority shareholders : Promoters
7
Consistent Returns over the last 3 years
- Along with generating 16.83% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Auro Labs. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Auro Labs. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Auro Labs.
16.83%
0.30
56.09%
Sensex
7.07%
0.61
11.53%
Quality key factors
Factor
Value
Sales Growth (5y)
-10.74%
EBIT Growth (5y)
-8.56%
EBIT to Interest (avg)
4.19
Debt to EBITDA (avg)
5.04
Net Debt to Equity (avg)
0.99
Sales to Capital Employed (avg)
1.00
Tax Ratio
20.27%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
19.99%
ROE (avg)
10.30%
Valuation Key Factors 
Factor
Value
P/E Ratio
57
Industry P/E
32
Price to Book Value
3.88
EV to EBIT
41.90
EV to EBITDA
29.26
EV to Capital Employed
2.45
EV to Sales
7.48
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.49%
ROE (Latest)
6.77%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
Technical Movement
28What is working for the Company
NET SALES(Latest six months)
Higher at Rs 18.23 cr
PBDIT(Q)
Highest at Rs 4.06 cr.
PBT LESS OI(Q)
Highest at Rs 1.56 cr.
PAT(Q)
Highest at Rs 1.95 cr.
EPS(Q)
Highest at Rs 3.13
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Auro Labs.
Net Sales - Latest six months
At Rs 18.23 cr has Grown at 196.42%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 1.95 cr has Grown at 642.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 0.26 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Latest six months
Higher at Rs 18.23 cr
than preceding 12 month period ended Dec 2025 of Rs 16.32 crMOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 4.06 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1.56 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 1.95 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 3.13
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)






